Tonapofylline

Overview

Tonapofylline (BG 9928) is an orally active and selective adenosine A 1 receptor antagonist with a K i of 7.4 nM for human adenosine A 1 receptor (hA 1 ), which displays 915-fold selectivity versus human adenosine A 2A receptor and 12-fold selectivity versus human adenosine A 2B receptor and is used in development for the treatment of heart failure.

Application

Products | Products > Disease Areas > Parkinson's Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Cardiovascular Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Adenosine Receptor

Product Information

• Catalog No.: HY-14873
• CAS No.: 340021-17-2
• Molecular Formula: C22H32N4O4
• Molecular Weight: 416.51
• Purity: 98.99%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (6.00 mM); Clear solution
• Availability: In-stock

Source

Original product source